Datatrak International, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 06, 2019 at 02:21 pm EST
Share
DATATRAK International, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 2.028 million compared to USD 1.846 million a year ago. Operating income was USD 78,640 compared to USD 91,869 a year ago. Net income was USD 81,927 compared to USD 91,550 a year ago. Basic earnings per share was USD 0.03 compared to USD 0.04 a year ago. For the nine months, sales was USD 5.833 million compared to USD 5.532 million a year ago. Operating income was USD 271,700 compared to USD 139,433 a year ago. Net income was USD 278,669 compared to USD 141,917 a year ago. Basic earnings per share was USD 0.12 compared to USD 0.06 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
